ConductScience.org, home

Paper16440366

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.

Yeo W and 1 other. Hepatology, 2006. Cited by 384 papers, by iCite.

Cite this record

ConductScience Library. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Papers, record 16440366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16440366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.
PubMed
Journal
Hepatology
PubMed
Year
2006
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
384
iCite
Relative citation ratio, by iCite
10.1
iCite
Revised in PubMed
2022-04-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yeo WWinnie
2Johnson PJPhilip J

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Hepatitis B virusMajor topic
Hepatitis B, ChronicMajor topic
Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Murine-Derived
Antibodies, Neoplasm
DNA, Viral
Hepatitis B Core Antigens
Hepatitis B Surface Antigens
Humans
Lamivudine
Recurrence
Risk Factors
Rituximab
Virus Activation

Source PubMed

Download CSV of topics

Cited by145

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 384 citations.

PMIDTitleJournalYearIn PapersSource
42281419KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA).Clin Mol Hepatol2026https://conductscience.org/library/papers/42281419PubMed
42230734True reactivation versus transient viremia: a retrospective analysis of HBV reactivation in resolved infection.Sci Rep2026https://conductscience.org/library/papers/42230734PubMed
42176073Breakthroughs in HBV-related HCC Therapy: The Unmatched Potential of Immune Checkpoint Inhibitors.Curr Treat Options Oncol2026https://conductscience.org/library/papers/42176073PubMed
38616853Hepatitis B virus reactivation in patients treated with monoclonal antibodies.World J Virol2024https://conductscience.org/library/papers/38616853PubMed
38570803Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy.Virol J2024https://conductscience.org/library/papers/38570803PubMed
38546893Investigating the correlation between prominent viruses and hematological malignancies: a literature review.Med Oncol2024https://conductscience.org/library/papers/38546893PubMed
38256527Hepatitis B Virus Reactivation with Immunosuppression: A Hidden Threat?J Clin Med2024https://conductscience.org/library/papers/38256527PubMed
37731995Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era.World J Gastroenterol2023https://conductscience.org/library/papers/37731995PubMed
37695530Hepatitis B reactivation is a rare event among patients with resolved infection undergoing anti-CD20 antibodies in monotherapy without antiviral prophylaxis: results from the HEBEM study.J Neurol2024https://conductscience.org/library/papers/37695530PubMed
36902786The Multiple Facets and Disorders of B Cell Functions in Hepatitis B Virus Infection.J Clin Med2023https://conductscience.org/library/papers/36902786PubMed
36847156HBcAb positivity increases the risk of postoperative complications after extended hemihepatectomy for hilar cholangiocarcinoma.Cancer Med2023https://conductscience.org/library/papers/36847156PubMed
36169566
Occult hepatitis B virus infection in patients with chronic liver disease of different etiology in a Brazilian referral center: comparison of two different hepatitis B virus deoxyribonucleic acid amplification protocols: a cross-sectional study.
Sao Paulo Med J2022https://conductscience.org/library/papers/36169566PubMed
36016402Hepatitis B Surface Antibody (Anti-HBs) Kinetics during Rituximab Chemotherapy and Performance of Hepatitis B Vaccine before Immunosuppression: Two Prospective Studies.Viruses2022https://conductscience.org/library/papers/36016402PubMed
35763632Frequency of Hepatitis B Markers in Systemic Lupus Erythematosus Patients in Iran.Asian Pac J Cancer Prev2022https://conductscience.org/library/papers/35763632PubMed
35712098Long-Term Safety of Rituximab in DLBCL Patients With Hepatitis B-Related Cirrhosis: A Retrospective Case Series.Front Med (Lausanne)2022https://conductscience.org/library/papers/35712098PubMed
35566572Effect of an Electronic Alert System on Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Drug Therapy.J Clin Med2022https://conductscience.org/library/papers/35566572PubMed
35430783KASL clinical practice guidelines for management of chronic hepatitis B.Clin Mol Hepatol2022https://conductscience.org/library/papers/35430783PubMed
35071501Hepatitis B virus reactivation in rheumatoid arthritis.World J Clin Cases2022https://conductscience.org/library/papers/35071501PubMed
34621337COVID-19 Pandemic Impact on Cord Blood Collection for Stem Cell Use and Actual Perspectives.Maedica (Bucur)2021https://conductscience.org/library/papers/34621337PubMed
34277431HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies.Front Oncol2021https://conductscience.org/library/papers/34277431PubMed

See all 145 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16440366

GET https://conductscience.org/api/papers/v1/16440366/cited_by?page=2